Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SRC inhibitors(Tyrosine-protein kinase SRC inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 29 Oct 2024 | |
Diabetes Mellitus | Discovery | - | 29 Oct 2024 | |
Gout | Discovery | - | 29 Oct 2024 | |
Lung Diseases | Discovery | - | 29 Oct 2024 | |
Malaria | Discovery | - | 29 Oct 2024 | |
Neoplasms | Discovery | - | 29 Oct 2024 | |
Neurodegenerative Diseases | Discovery | - | 29 Oct 2024 | |
Renal Insufficiency | Discovery | - | 29 Oct 2024 |